BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1374221)

  • 1. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: comparison with adult blood donors.
    Tanaka E; Kiyosawa K; Sodeyama T; Hayata T; Ohike Y; Nakano Y; Yoshizawa K; Furuta S; Watanabe Y; Watanabe J
    Am J Trop Med Hyg; 1992 Apr; 46(4):460-4. PubMed ID: 1374221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study.
    Koulentaki M; Spanoudakis S; Kantidaki E; Drandakis P; Tzagarakis N; Biziagos E; Moschandrea J; Kouroumalis EA
    J Viral Hepat; 1999 May; 6(3):243-8. PubMed ID: 10607237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to hepatitis viruses in blood donors with a clinical history of hepatitis.
    Vranckx R; Muylle L
    Zentralbl Bakteriol; 1992 Apr; 276(4):540-7. PubMed ID: 1319249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped.
    Cunningham SJ; Cunningham R; Izmeth MG; Baker B; Hart CA
    Epidemiol Infect; 1994 Feb; 112(1):195-200. PubMed ID: 7509754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan.
    Tanaka H; Hiyama T; Tsukuma H; Okubo Y; Yamano H; Kitada A; Fujimoto I
    Cancer Causes Control; 1994 Sep; 5(5):409-13. PubMed ID: 7999962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan.
    Khan M; Husain M; Yano M; Hashizume K; Yousuf M; Tanaka E; Matsumoto A; Furuta S; Kiyosawa K
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():28-31. PubMed ID: 7689505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The hepatitis C virus infection of Moscow blood donors].
    Sychev Av; Mikhaĭlov MI
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):80-3. PubMed ID: 8067123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
    Kuperan P; Choon AT; Ding SH; Lee G
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of HBV and HCV infections in plasma donors with recently increased ALT level].
    Li F
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Aug; 14(4):217-9. PubMed ID: 7511485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on HDV and HCV infection in plasma donors with positive HBsAg].
    Wang SP; Ding H; Zhao OK
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Jul; 28(4):223-4. PubMed ID: 7531135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to hepatitis C virus in blood donors.
    Ferroni P; Tagger A; Ribero ML; Grossi A; Pregliasco F; Pasquali ML; Salvaneschi S
    Eur J Epidemiol; 1990 Sep; 6(3):326-8. PubMed ID: 2174795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A, B and C seroprevalence in Pakistan.
    Agboatwalla M; Isomura S; Miyake K; Yamashita T; Morishita T; Akram DS
    Indian J Pediatr; 1994; 61(5):545-9. PubMed ID: 7538098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.
    Darwish MA; Raouf TA; Rushdy P; Constantine NT; Rao MR; Edelman R
    Am J Trop Med Hyg; 1993 Oct; 49(4):440-7. PubMed ID: 7692754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrafamilial transmission of hepatitis C virus (HCV): a major mode of spread in the Saudi Arabia population.
    al Nasser MN
    Ann Trop Paediatr; 1992; 12(2):211-5. PubMed ID: 1381898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.